Pathogenic B Cells in Sjogren's Syndrome
干燥综合征中的致病性 B 细胞
基本信息
- 批准号:8102494
- 负责人:
- 金额:$ 41.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-07-21 至 2016-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAffectAntibodiesAntibody FormationAntigensAutoantibodiesAutoimmune ProcessB-LymphocytesBindingBiochemicalBlood VesselsCellsCharacteristicsCross ReactionsDataDiseaseDisease modelEpitopesExocrine GlandsFunctional disorderGlandHarvestHumanImmunoglobulin GImmunoglobulin-Secreting CellsImpairmentIndividualInduction of ApoptosisJointsKidneyKnowledgeLeadLung diseasesLymphocytic InfiltrateLymphomaMethodsMinor salivary gland structureModelingMonoclonal AntibodiesMusMuscarinic Acetylcholine ReceptorMuscarinicsNOD/SCID mouseOklahomaPathogenicityPatientsPhysiologicalProcessProductionReceptors, Antigen, B-CellRecombinantsRiskSCID MiceSalivaSalivarySalivary GlandsSerumSignal TransductionSjogren&aposs SyndromeSkinSpecificitySpleenStructure of germinal center of lymph nodeSymptomsT-LymphocyteTestingTissuesTranslational ResearchTransplantationXerostomiaaquaporin 5autoreactive B celleye drynesshuman diseaseinnovationmouse modelreceptorsalivary cellsystemic autoimmune diseasewater channel
项目摘要
Sjogren's syndrome is a systemic autoimmune disease that most commonly targets the exocrine glands and is characterized by persistent dry eyes and mouth as well as extra-glandular involvement including blood vessel, skin, kidney, joints, and lung disease along with an increased risk of lymphoma. Salivary gland lymphocytic infiltrates are a pathological finding in the disease. The serum of these patients commonly contains autoantibodies to Ro (SS-A) and La (SS-B). Other specificities are present, including those towards muscarinic receptors. There are strong data supporting significant autoreactive B cell expansion, hyperreactivity
and antibody formation in exocrine glands of Sjogren's patient, including the presence of anti-Ro and -La specific B cells. The evidence is strong that B cells infiltrating the salivary glands of Sjogren's patients make autoantibodies that are in part responsible for the exocrine glandular dysfunction.
This proposal will test the hypothesis that this is the case, and will address the pathogenic mechanisms underlying this dysfunction. We will utilize an innovative, humanized model of Sjogren's in which human salivary tissue is transplanted into NOD SCID mice. So transplanted mice are already available (see Preliminary Data). In addition, we will use an innovative method of producing recombinant monoclonal antibodies to study the autoantibody repertoire produced in the salivary gland of humans with Sjogren's. Already we have harvested B cells from minor salivary glands and begun the process of producing recombinant monoclonals antibodies (see Preliminary Data). First, we will produce recombinant monoclonal antibodies from B cells infiltrating the salivary glands of humans with Sjogren's syndrome. Then, these monoclonal antibodies will be tested for pathogenicity, that is, the ability to reduce salivary flow in either normal mice, or the xenotransplanted Sjogren's mouse model. We will study the binding specificity of pathogenic autoantibodies. Furthermore, the pathogenic mechanisms by which these antibodies cause the characteristic salivary gland dysfunction will be elucidated.
Sjogren综合征是一种系统性的自身免疫性疾病,最常见的是针对外分泌腺体,其特征是持续的干眼睛和口腔以及glo骨外受累,包括血管,皮肤,肾脏,关节和肺部病以及淋巴瘤的风险增加。唾液腺淋巴细胞浸润是该疾病的病理发现。这些患者的血清通常包含自身抗体(SS-A)和LA(SS-B)。存在其他特异性,包括毒蕈碱受体的特异性。有强大的数据支持明显的自动反应性B细胞扩展,过度反应性
Sjogren患者的外分泌腺中的抗体形成,包括抗RO和-LA特异性B细胞的存在。有证据表明,B细胞渗入Sjogren患者的唾液腺产生的自身抗体,部分原因是外分泌腺功能障碍。
该提案将检验以下假设,即这种情况,并将解决该功能障碍的致病机制。我们将利用一种创新的,人性化的模型,其中人类唾液组织被移植到点头SCID小鼠中。因此,已移植的小鼠已经可用(请参阅初步数据)。此外,我们将使用一种创新的方法来产生重组单克隆抗体来研究用Sjogren的人类唾液腺中产生的自身抗体库。我们已经从较小的唾液腺中收集了B细胞,并开始产生重组单克隆抗体的过程(请参阅初步数据)。首先,我们将从B细胞中产生重组单克隆抗体,浸润人类患有Sjogren综合征的唾液腺。然后,将测试这些单克隆抗体的致病性,即降低正常小鼠中唾液流动的能力,或者sjogren sjogren的小鼠模型。我们将研究病原自身抗体的结合特异性。此外,将阐明这些抗体引起特征性唾液腺功能障碍的致病机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert Hal Scofield其他文献
Robert Hal Scofield的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robert Hal Scofield', 18)}}的其他基金
Autoimmunity in Post-Traumatic Stress Disorder
创伤后应激障碍中的自身免疫
- 批准号:
10427168 - 财政年份:2020
- 资助金额:
$ 41.78万 - 项目类别:
Autoimmunity in Post-Traumatic Stress Disorder
创伤后应激障碍中的自身免疫
- 批准号:
10704565 - 财政年份:2020
- 资助金额:
$ 41.78万 - 项目类别:
ShEEP Request for Peggy Sue by Bio-Techne
ShEEP 请求 Bio-Techne 提供 Peggy Sue
- 批准号:
9906453 - 财政年份:2019
- 资助金额:
$ 41.78万 - 项目类别:
Mitochondrial dysfunction, metabolic syndrome and oxidative damage in Sjogren's Syndrome
干燥综合征中的线粒体功能障碍、代谢综合征和氧化损伤
- 批准号:
9387723 - 财政年份:2017
- 资助金额:
$ 41.78万 - 项目类别:
相似国自然基金
YTHDF3调控CXCL13表达影响黑色素瘤免疫微环境及PD-1抗体疗效的机制
- 批准号:82303866
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
AID介导抗体重链非编码区重组调控质膜BCR密度并影响记忆B细胞命运决定的研究
- 批准号:32370948
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
P29单克隆抗体的3-羟基丁酰化修饰对其稳定性影响及提升抗泡型包虫病作用的研究
- 批准号:82360402
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
母传抗体水平和疫苗初种年龄对儿童麻疹特异性抗体动态变化的影响
- 批准号:82304205
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:青年科学基金项目
心衰患者中单克隆β1-肾上腺素受体自身抗体的筛选及其对受体构象影响的研究
- 批准号:32271156
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
相似海外基金
Designing Rational Combinations to Improve CAR T Cell Therapy for Prostate Cancer
设计合理的组合以改善前列腺癌的 CAR T 细胞疗法
- 批准号:
10752046 - 财政年份:2024
- 资助金额:
$ 41.78万 - 项目类别:
Alternatively spliced cell surface proteins as drivers of leukemogenesis and targets for immunotherapy
选择性剪接的细胞表面蛋白作为白血病发生的驱动因素和免疫治疗的靶点
- 批准号:
10648346 - 财政年份:2023
- 资助金额:
$ 41.78万 - 项目类别:
Cellular mechanisms for the degeneration and aging of human rotator cuff tears
人类肩袖撕裂变性和衰老的细胞机制
- 批准号:
10648672 - 财政年份:2023
- 资助金额:
$ 41.78万 - 项目类别:
A First-in-class Topical Immunoregulatory Therapeutic for Psoriasis
一流的牛皮癣局部免疫调节疗法
- 批准号:
10820331 - 财政年份:2023
- 资助金额:
$ 41.78万 - 项目类别: